The use of AI in the early detection of disease

  • June 14, 2023 5:30 PM - 8:30 PM
  • Online or in person at the Royal Society

Recent developments have shown the potential for the use of AI in the early detection of diseases such as cancer, Alzheimer's and retinal diseases. What is the current state of this technology? What will this mean for clinicians and patients? What are the ethical implications? How do we regulate this rapidly evolving technology? These are just some of the questions that we hope to explore at this discussion event.

David Crosby
Head of Early Detection Research, Cancer Research UK
Mike Oldham
Director of Early Detection of Neurodegenerative Diseases, Alzheimer's Research UK
Jessica Morley
Oxford Internet Institute, University of Oxford
Tobias Rijken
Co-Founder and Chief Technology Officer, Kheiron Medical Technologies

This discussion appeared in the FST journal below.

This edition of the journal welcomes a guest editorial from Sir Adrian Smith. It explores Net Zero by 2050, the National semiconductor strategy, REF 2028, AI in disease detection and Equity, Diversity and Inclusion in STEM. Find also a viewpoint by Lord Willetts: Identifying the technologies that will be key to the UK’s future.

Volume 23, Issue 6